The effect of sibutramine on non alcoholic fatty liver
Not Applicable
- Conditions
- non alcoholic fatty liver.Diseases of liverk70, k77
- Registration Number
- IRCT201012275483N1
- Lead Sponsor
- School of health & nutrition, Aras international university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
non-alcoholic fatty liver disease, having 20 to 50 years old of both sexes, having BMI 30kg/m2 or more, willing to participate
Exclusion criteria: Presence of thyroid disorders, diabetes, or uncontrolled hypertension, use of glucose, cholesterol, or triglyceride lowering drugs, estrogen or progesterone usage, supplementation of vitamin C, or E over the two months prior to the study, menopausal women, smoking and alcohol use, being athletes
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver echogenicity. Timepoint: before and after intervention. Method of measurement: sonography.;Weight. Timepoint: every two week. Method of measurement: Nestle scale.
- Secondary Outcome Measures
Name Time Method